Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter Audit

BACKGROUND: Botulinum toxin A (BoNT‐A) is an effective treatment for cervical dystonia. Nevertheless, up to 30% to 40% patients discontinue treatment, often because of poor response. The British Neurotoxin Network (BNN) recently published guidelines on the management of poor response to BoNT‐A in ce...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mov Disord Clin Pract
Autores principales: Tucker, Harry, Osei‐Poku, Foster, Ashton, Diane, Lally, Rachael, Jesuthasan, Aaron, Latorre, Anna, Bhatia, Kailash P., Alty, Jane E., Kobylecki, Christopher
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Research Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088097/
https://ncbi.nlm.nih.gov/pubmed/33977116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.13181
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares